taurolidine has been researched along with Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Fiocco, M; Frakking, FNJ; Loeffen, Y; van de Ven, CP; van de Wetering, MD; van den Bosch, CH; van der Bruggen, JT; van der Steeg, AFW; Wijnen, MHWA | 1 |
| Bottos, P; Brescia, F; Da Ros, V; Fabiani, F; Moreal, C; Nadalini, E; Pittiruti, M; Scoppettuolo, G; Zanier, C | 1 |
| Eid, N; Goetz, C; Llorens, M; Longo, R; Ouamara, N; Platini, C; Quétin, P; Sellies, J | 1 |
| Handrup, MM; Møller, JK; Schrøder, H | 1 |
| Frei, K; Möhler, H; Pfirrmann, RW | 1 |
| Ammann, RA; Besuden, MM; Bode, U; Fleischhack, G; Simon, A; Wiszniewsky, G | 1 |
| Bouchier-Hayes, DJ; Hallihan, P; Neary, PM; Pfirrmann, RW; Redmond, HP; Wang, JH | 1 |
| Bulut, D; Chromik, AM; Daigeler, A; Flier, A; Hahn, SA; Harati, K; May, C; Mittelkötter, U; Ritter, PR; Roschinsky, J; Sülberg, D; Uhl, W | 1 |
| Koldehoff, M; Zakrzewski, JL | 1 |
| Braumann, C; Jacobi, CA; Menenakos, C | 1 |
| Braumann, C; Dubiel, W; Jacobi, CA; Müller, JM; Tangermann, J | 1 |
4 review(s) available for taurolidine and Neoplasms
| Article | Year |
|---|---|
Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents (review).
Topics: Antineoplastic Agents; Apoptosis; Cell Survival; Dioxolanes; Humans; Neoplasms; Oxidation-Reduction; Perioperative Care; Reactive Oxygen Species; Taurine; Thiadiazines | 2014 |
The evolving role of taurolidine in cancer therapy.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Taurine; Thiadiazines | 2010 |
Taurolidine--a new drug with anti-tumor and anti-angiogenic effects.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Clinical Trials as Topic; Cytokines; Humans; Models, Animal; Neoplasms; Protein Biosynthesis; Taurine; Thiadiazines; Vascular Endothelial Growth Factor A | 2005 |
Novel anti-angiogenic compounds for application in tumor therapy - COP9 signalosome-associated kinases as possible targets.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; COP9 Signalosome Complex; Curcumin; Drug Screening Assays, Antitumor; Emodin; Humans; Models, Molecular; Multiprotein Complexes; Neoplasms; Peptide Hydrolases; Protein Kinase Inhibitors; Structure-Activity Relationship; Taurine; Thiadiazines | 2008 |
4 trial(s) available for taurolidine and Neoplasms
| Article | Year |
|---|---|
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.
Topics: Catheter-Related Infections; Central Venous Catheters; Child; Citrates; Citric Acid; Heparin; Humans; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Sepsis | 2023 |
Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
Topics: Aged; Anti-Infective Agents; Biofilms; Catheter-Related Infections; Catheters, Indwelling; Central Venous Catheters; Female; Humans; Incidence; Male; Middle Aged; Neoplasms; Primary Prevention; Prospective Studies; Taurine; Thiadiazines; Treatment Outcome | 2017 |
Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.
Topics: Adolescent; Adult; Anti-Infective Agents; Anticoagulants; Central Venous Catheters; Child; Child, Preschool; Female; Heparin; Humans; Infant; Infant, Newborn; Infection Control; Infections; Male; Neoplasms; Prospective Studies; Taurine; Thiadiazines | 2013 |
Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
Topics: Adult; Anti-Infective Agents; Bacteremia; Catheterization, Central Venous; Female; Humans; Male; Neoplasms; Pilot Projects; Prosthesis-Related Infections; Solutions; Taurine; Thiadiazines; Treatment Outcome | 2004 |
3 other study(ies) available for taurolidine and Neoplasms
| Article | Year |
|---|---|
Taurolidine lock in the treatment of colonization and infection of totally implanted venous access devices in cancer patients.
Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Humans; Neoplasms; Retrospective Studies; Sepsis; Taurine; Thiadiazines | 2023 |
Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients.
Topics: Adolescent; Adult; Anti-Infective Agents; Catheterization, Central Venous; Child; Child, Preschool; Cohort Studies; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Neoplasms; Prospective Studies; Taurine; Thiadiazines | 2008 |
Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines.
Topics: Acetylcysteine; Antineoplastic Agents; Caspases; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glutathione; Humans; Neoplasms; Reactive Oxygen Species; Taurine; Thiadiazines | 2010 |